Sensus Healthcare(US:SRTS) Prnewswireยท2025-08-22 14:00Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Sensus Healthcare, Inc. and its officers or directors [1] Financial Performance - Sensus reported a second quarter GAAP earnings-per-share of -$0.06, missing estimates by $0.09 [2] - Revenue for the second quarter was $7.3 million, reflecting a year-over-year decline of 20.7% and missing estimates by $2 million [2] - The revenue decline was primarily due to a lower number of units sold to a large customer, although there was some growth in recurring revenue from Fair Deal Agreements [2] Stock Market Reaction - Following the financial results announcement, Sensus's stock price dropped by $1.89 per share, or 35.32%, closing at $3.46 per share on August 8, 2025 [3]